139 related articles for article (PubMed ID: 18762809)
1. The atypical Rho GTPase RhoBTB2 is required for expression of the chemokine CXCL14 in normal and cancerous epithelial cells.
McKinnon CM; Lygoe KA; Skelton L; Mitter R; Mellor H
Oncogene; 2008 Nov; 27(54):6856-65. PubMed ID: 18762809
[TBL] [Abstract][Full Text] [Related]
2. Ectopic expression of RhoBTB2 inhibits migration and invasion of human breast cancer cells.
Ling LJ; Lu C; Zhou GP; Wang S
Cancer Biol Ther; 2010 Dec; 10(11):1115-22. PubMed ID: 20930524
[TBL] [Abstract][Full Text] [Related]
3. RhoBTB2 (DBC2) functions as tumor suppressor via inhibiting proliferation, preventing colony formation and inducing apoptosis in breast cancer cells.
Mao H; Zhang L; Yang Y; Sun J; Deng B; Feng J; Shao Q; Feng A; Song B; Qu X
Gene; 2011 Oct; 486(1-2):74-80. PubMed ID: 21801820
[TBL] [Abstract][Full Text] [Related]
4. Regulation of RhoBTB2 by the Cul3 ubiquitin ligase complex.
Wilkins A; Carpenter CL
Methods Enzymol; 2008; 439():103-9. PubMed ID: 18374159
[TBL] [Abstract][Full Text] [Related]
5. A novel tumor suppressor gene RhoBTB2 (DBC2): frequent loss of expression in sporadic breast cancer.
Mao H; Qu X; Yang Y; Zuo W; Bi Y; Zhou C; Yin H; Deng B; Sun J; Zhang L
Mol Carcinog; 2010 Mar; 49(3):283-9. PubMed ID: 19937980
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of CXCL14 induced colorectal cancer migration and invasion.
Cao B; Yang Y; Pan Y; Jia Y; Brock MV; Herman JG; Guo M
Discov Med; 2013 Oct; 16(88):137-47. PubMed ID: 24099668
[TBL] [Abstract][Full Text] [Related]
7. De novo variants in RHOBTB2, an atypical Rho GTPase gene, cause epileptic encephalopathy.
Belal H; Nakashima M; Matsumoto H; Yokochi K; Taniguchi-Ikeda M; Aoto K; Amin MB; Maruyama A; Nagase H; Mizuguchi T; Miyatake S; Miyake N; Iijima K; Nonoyama S; Matsumoto N; Saitsu H
Hum Mutat; 2018 Aug; 39(8):1070-1075. PubMed ID: 29768694
[TBL] [Abstract][Full Text] [Related]
8. Hsp90-dependent assembly of the DBC2/RhoBTB2-Cullin3 E3-ligase complex.
Manjarrez JR; Sun L; Prince T; Matts RL
PLoS One; 2014; 9(3):e90054. PubMed ID: 24608665
[TBL] [Abstract][Full Text] [Related]
9. RhoBTB2 is a substrate of the mammalian Cul3 ubiquitin ligase complex.
Wilkins A; Ping Q; Carpenter CL
Genes Dev; 2004 Apr; 18(8):856-61. PubMed ID: 15107402
[TBL] [Abstract][Full Text] [Related]
10. DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancer.
Choi YM; Kim KB; Lee JH; Chun YK; An IS; An S; Bae S
Oncogene; 2017 May; 36(20):2802-2812. PubMed ID: 27941885
[TBL] [Abstract][Full Text] [Related]
11. The tumor suppressor RhoBTB1 controls Golgi integrity and breast cancer cell invasion through METTL7B.
McKinnon CM; Mellor H
BMC Cancer; 2017 Feb; 17(1):145. PubMed ID: 28219369
[TBL] [Abstract][Full Text] [Related]
12. RhoBTB2 gene in breast cancer is silenced by promoter methylation.
Tang W; Wang C; Fu F; Chen Q
Int J Mol Med; 2014 Mar; 33(3):722-8. PubMed ID: 24356943
[TBL] [Abstract][Full Text] [Related]
13. Fasudil, a Rho kinase inhibitor, suppresses tumor growth by inducing CXCL14/BRAK in head and neck squamous cell carcinoma.
Miyamoto C; Maehata Y; Motohashi K; Ozawa S; Ikoma T; Hidaka K; Wada-Takahashi S; Takahashi SS; Yoshino F; Yoshida A; Kubota E; Hata R; Lee MC
Biomed Res; 2014; 35(6):381-8. PubMed ID: 25743344
[TBL] [Abstract][Full Text] [Related]
14. Expression of tumour-suppressing chemokine BRAK/CXCL14 reduces cell migration rate of HSC-3 tongue carcinoma cells and stimulates attachment to collagen and formation of elongated focal adhesions in vitro.
Sato K; Ozawa S; Izukuri K; Kato Y; Hata R
Cell Biol Int; 2010 Apr; 34(5):513-22. PubMed ID: 20067447
[TBL] [Abstract][Full Text] [Related]
15. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo.
Shurin GV; Ferris RL; Tourkova IL; Perez L; Lokshin A; Balkir L; Collins B; Chatta GS; Shurin MR
J Immunol; 2005 May; 174(9):5490-8. PubMed ID: 15843547
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of proximal promoter of gene for human BRAK/CXCL14, a tumor-suppressing chemokine.
Komori R; Ozawa S; Kato Y; Shinji H; Kimoto S; Hata R
Biomed Res; 2010 Apr; 31(2):123-31. PubMed ID: 20460740
[TBL] [Abstract][Full Text] [Related]
17. Expression of CXCL14 and its anticancer role in breast cancer.
Gu XL; Ou ZL; Lin FJ; Yang XL; Luo JM; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 Oct; 135(3):725-35. PubMed ID: 22910931
[TBL] [Abstract][Full Text] [Related]
18. Missense Variants in RHOBTB2 Cause a Developmental and Epileptic Encephalopathy in Humans, and Altered Levels Cause Neurological Defects in Drosophila.
Straub J; Konrad EDH; Grüner J; Toutain A; Bok LA; Cho MT; Crawford HP; Dubbs H; Douglas G; Jobling R; Johnson D; Krock B; Mikati MA; Nesbitt A; Nicolai J; Phillips M; Poduri A; Ortiz-Gonzalez XR; Powis Z; Santani A; Smith L; Stegmann APA; Stumpel C; Vreeburg M; ; Fliedner A; Gregor A; Sticht H; Zweier C
Am J Hum Genet; 2018 Jan; 102(1):44-57. PubMed ID: 29276004
[TBL] [Abstract][Full Text] [Related]
19. Data Mining Suggests That CXCL14 Gene Silencing in Colon Cancer Is Due to Promoter Methylation.
Wang Y; Wang S; Niu Y; Ma B; Li J
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003215
[TBL] [Abstract][Full Text] [Related]
20. The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells.
Fazi B; Proserpio C; Galardi S; Annesi F; Cola M; Mangiola A; Michienzi A; Ciafrè SA
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
